-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Meridian Bioscience Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
- Meridian Bioscience Inc Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$982K, a 84.6% decline year-over-year.
- Meridian Bioscience Inc Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$524K, a 80.6% increase year-over-year.
- Meridian Bioscience Inc annual Nonoperating Income (Expense) for 2022 was -$74K, a 97.1% increase from 2021.
- Meridian Bioscience Inc annual Nonoperating Income (Expense) for 2021 was -$2.58M, a 27.2% decline from 2020.
- Meridian Bioscience Inc annual Nonoperating Income (Expense) for 2020 was -$2.03M, a 77.8% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)